The US pandemic influenza implementation plan at six months.

The US pandemic influenza implementation plan at six months. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The US pandemic influenza implementation plan at six months. Abstract Text:

Stephen S Morse,

The US pandemic influenza implementation plan at six months. Publishing Authors By Initials

SS Morse,

For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

PUBMED ID PMID:

MEDLINE DATE:

The US pandemic influenza implementation plan at six months. Journal Published:

PUBLICATION TYPE: Review

Journal: Nature medicine

VOLUME: 13

Page Numbers: 681-4

Journal Abbreviation: Nat. Med.

ISSN: 1078-8956

DAY: 3

MONTH: Jun

YEAR: 2007

The US pandemic influenza implementation plan at six months. Information

Number of References: 21

LANGUAGE: eng

NlmUniqueID: 9502015

The US pandemic influenza implementation plan at six months. Keywords Mesh Terms:

KEYWORDS: United States

MESH TERMS: prevention & control

Chemical & Substance for Abstract: The US pandemic influenza implementation plan at six months. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The US pandemic influenza implementation plan at six months.

AFFILIATION: Department of Epidemiology and Center for Public Health Preparedness/National Center for Disaster Preparedness, Mailman School of Public Health, Columbia University, New York, New York 10032, USA. ssm20@columbia.edu

Country: United States

AGENCY: United States PHS

GRANT: U90/CCU224241

ACRONYM: CI

MEDLINETA: Nat Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The US pandemic influenza implementation plan at six months Related Publications

• A dinoflagellate AAA family member rescues a conditional yeast G1/S phase cyclin mutant through increased CLB5 accumulation.
• Advances in pharmacogenomics of antiretrovirals: an update.
• Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
• Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.
• Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.
• Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
• Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.
• Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry.
• Direct selection of RNA beacon aptamers.
• Drug interactions between proton pump inhibitors and antiretroviral drugs.
• Duplicate publication.
• Effects of pyriproxyfen on California red scale (Hemiptera: Diaspididae) development and reproduction.
• Functional deficiency in IL-7 caused by an N-ethyl-N-nitrosourea-induced point mutation.
• Genome-wide analysis of transcriptional dependence and probable target sites for Abf1 and Rap1 in Saccharomyces cerevisiae.
• Global infectious disease surveillance and health intelligence.
• Global preparedness for public health emergencies.
• HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries.
• Hierarchical assembly of the siliceous skeletal lattice of the hexactinellid sponge Euplectella aspergillum.
• High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation.
• Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
• Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
• Pandemic influenza: studying the lessons of history.
• Rotationally resolved spectroscopy of jet-cooled NbMo.
• Simulations of dynamics and viscoelasticity in highly entangled solutions of semiflexible rods.
• Technology evaluation: BLP-25, Biomira Inc.
• The US pandemic influenza implementation plan at six months.
• Toxicity of systemic neonicotinoid insecticides to avocado thrips in nursery avocado trees.
• Transcription factor access to promoter elements.
• Use of the finite element method to assess impact of current on forearm and wrist during an electrical accident.
• Wide dynamic range germanium detector for perturbation crystallography.